Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engineProteros to support Adrestia in the discovery of first-in-class drugs for intractable genetic diseasesSignals...
-
LOUISVILLE, Colo., Oct. 25, 2022 (GLOBE NEWSWIRE) -- JumpCloud Inc. today announced the upcoming launch of JumpCloud Remote Assist, a free cloud-based solution that allows IT admins and MSPs to...
-
Tallahassee, FL. and San Francisco, CA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- F&I Sentinel and Informed.IQ are partnering to evolve digital lending by providing a comprehensive service focused on...
-
MONTREAL and SAN FRANCISCO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Coveo Solutions Inc. (“Coveo” or the “Company”) (TSX: CVO), a leader in AI-powered relevance platforms that transform search,...
-
SAN DIEGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
-
OTTAWA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Janitors and their allies will hold a rally today at noon at the Fairmont Château Laurier in downtown Ottawa. Numerous grievances have been filed against...
-
JERSEY CITY, N.J., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced it will attend the...
-
Third Quarter 2022: Net earnings of $2.0 million or $0.57 per share, compared to $1.9 million or $0.53 per share in Q3 2021Total revenue increased 15% from Q3 2021Net interest income (tax-equivalent)...
-
BOSTON, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Thursday, Nov. 3 at 4:30...
-
NEW HAVEN, Conn., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in direct DNA modification developing novel cancer therapeutics, has been selected by the National Cancer Institute...